Dyne Therapeutics, Inc.
DYN
55 insider filings · Latest: Oct 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Apr 27 8:48 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 35,947 | $18.26 | $656.4K | — | View → |
| Apr 27, 2026 | Apr 27 8:48 PM | Atlas Venture Fund XI, LP | Proposed Sale | 90,943 | $18.26 | $1.7M | — | View → |
| Apr 27, 2026 | Apr 27 8:48 PM | Atlas Venture Associates XI, LP | Proposed Sale | 894 | $18.26 | $16.3K | — | View → |
| Apr 24, 2026 | Apr 24 8:47 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 28,583 | $18.90 | $540.2K | — | View → |
| Apr 24, 2026 | Apr 24 8:46 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 36,345 | $18.90 | $686.9K | — | View → |
| Apr 24, 2026 | Apr 24 8:46 PM | Atlas Venture Fund XI, LP | Proposed Sale | 72,310 | $18.90 | $1.4M | — | View → |
| Apr 24, 2026 | Apr 24 8:45 PM | Atlas Venture Associates XI, LP | Proposed Sale | 710 | $18.90 | $13.4K | — | View → |
| Apr 23, 2026 | Apr 23 8:46 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 15,148 | $19.67 | $298.0K | — | View → |
| Apr 23, 2026 | Apr 23 8:45 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 19,261 | $19.67 | $378.9K | — | View → |
| Apr 23, 2026 | Apr 23 8:45 PM | Atlas Venture Fund XI, LP | Proposed Sale | 38,322 | $19.67 | $753.8K | — | View → |
| Apr 23, 2026 | Apr 23 8:45 PM | Atlas Venture Associates XI, LP | Proposed Sale | 377 | $19.67 | $7.4K | — | View → |
| Apr 22, 2026 | Apr 23 8:15 PM | Dirk KerstenDirector | Sale | 2,652 | $20.00 | $53.0K | 4,196,573(I) | View → |
| Apr 21, 2026 | Apr 23 8:15 PM | Dirk KerstenDirector | Sale | 8,300 | $20.01 | $166.1K | 4,199,225(I) | View → |
| Apr 22, 2026 | Apr 22 10:27 PM | Jason P RhodesDirector | Sale | 287,956 | $19.68 | $5.7M | 1,285,704(I) | View → |
| Apr 21, 2026 | Apr 22 10:27 PM | Jason P RhodesDirector | Sale | 274,297 | $19.52 | $5.4M | 1,345,367(I) | View → |
| Apr 20, 2026 | Apr 22 10:27 PM | Jason P RhodesDirector | Sale | 272,049 | $20.06 | $5.5M | 1,402,200(I) | View → |
| Apr 22, 2026 | Apr 22 8:54 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 59,663 | $19.21 | $1.1M | — | View → |
| Apr 22, 2026 | Apr 22 8:53 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 75,866 | $19.21 | $1.5M | — | View → |
| Apr 22, 2026 | Apr 22 8:53 PM | Atlas Venture Fund XI, LP | Proposed Sale | 150,942 | $19.21 | $2.9M | — | View → |
| Apr 22, 2026 | Apr 22 8:52 PM | Atlas Venture Associates XI, LP | Proposed Sale | 1,485 | $19.21 | $28.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Jun 23 8:07 PM | Barry E GreeneDirector | Grant/Award | 57,463 | $20.87 | 57,463(D) | View → |
| Jun 5, 2026 | Jun 9 9:15 PM | Edward HurwitzDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:13 PM | David Charles LubnerDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:13 PM | Jason P RhodesDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:12 PM | Dirk KerstenDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:12 PM | Carlo IncertiDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:09 PM | Catherine Stehman-BreenDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Jun 5, 2026 | Jun 9 9:06 PM | Brian S PosnerDirector | Grant/Award | 35,152 | $17.04 | 35,152(D) | View → |
| Feb 12, 2026 | Feb 17 10:11 PM | John CoxDirector, CEO & President | Grant/Award | 285,000 | $16.00 | 285,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:10 PM | Douglas KerrChief Medical Officer | Grant/Award | 130,000 | $16.00 | 130,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:09 PM | Johanna Friedl-NadererChief Commercial Officer | Grant/Award | 90,000 | $16.00 | 90,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:08 PM | Erick LuceraChief Financial Officer | Grant/Award | 105,000 | $16.00 | 105,000(D) | View → |